Clinical Research (Life Science)
Pharmaceutical companies and CROs use Legit.Health to automate clinical endpoints in dermatology trials: automatic severity scoring (PASI, SCORAD, UAS), image quality assurance, and patient recruitment screening. This reduces variability, speeds up trials, and generates additional clinical data.
Pharmaceutical companies
Direct customers running formal clinical trials or retrospective studies.
Customers
| Customer | Country | Notes |
|---|---|---|
| Johnson & Johnson / Janssen | US | Psoriasis Phase 3, Retrospective AD & Pso |
| Sagimet Biosciences | US | Alopecia Phase 3 (via ICON) |
| Almirall | Spain | HS studies, DCT consultancy |
CROs (Contract Research Organizations)
Indirect channel: CROs integrate Legit.Health into their clinical trial platforms.
Customers and pipeline
| CRO | Country | Notes |
|---|---|---|
| Quantificare | France | Key partner. Sanofi AD trials (5 studies), Alopecia trial, Takeda AD |
| ICON | US | Almirall HS trial, Protagonist Therapeutics Psoriasis Phase 2 |
| PPD | US | Pipeline |
| Symbio Research | US | Pipeline |
| Fortrea | EU | Pipeline |
| Eurofins Bioskin | Germany | Pipeline |
Testimonial: Almirall
Diego Herrera (Almirall) and Taig Mac Carthy (Legit.Health) on digitalising clinical endpoints with AI.